Xcovery, Inc. - Product Pipeline Review - 2012

Global Markets Direct, June 2012, Pages: 27

Xcovery, Inc. – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “Xcovery, Inc. - Product Pipeline Review - 2012” provides data on the Xcovery, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Xcovery, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Xcovery, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Xcovery, Inc. - Brief Xcovery, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Xcovery, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Xcovery, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Xcovery, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Xcovery, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Xcovery, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Xcovery, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Xcovery, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Xcovery, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Xcovery, Inc.; Xcovery, Inc. - Key Therapeutics; Xcovery, Inc. - Pipeline Overview and Promising Molecules; Xcovery, Inc. - News; Xcovery, Inc. - Latest Updates; Xcovery, Inc. - Pipeline; Xcovery, Inc. - Discontinued/Dormant Projects

List of Tables
List of Figures
Xcovery, Inc. Snapshot
Xcovery, Inc. Overview
Key Information
Key Facts
Xcovery, Inc. – Research and Development Overview
Key Therapeutic Areas
Xcovery, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Xcovery, Inc. – Pipeline Products Glance
Xcovery, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Xcovery, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Xcovery, Inc. – Drug Profiles
X-339
Product Description
Mechanism of Action
R&D Progress
X-379
Product Description
Mechanism of Action
R&D Progress
X-396
Product Description
Mechanism of Action
R&D Progress
X-480
Product Description
Mechanism of Action
R&D Progress
X-82
Product Description
Mechanism of Action
R&D Progress
Xcovery, Inc. – Pipeline Analysis
Xcovery, Inc. – Pipeline Products by Therapeutic Class
Xcovery, Inc. – Pipeline Products By Target
Xcovery, Inc. – Pipeline Products by Route of Administration
Xcovery, Inc. – Pipeline Products By Mechanism of Action
Xcovery, Inc. – Recent Pipeline Updates
Xcovery, Inc. - Dormant Projects
Xcovery, Inc. – Locations And Subsidiaries
Head Office
Xcovery, Inc., Recent Developments
Xcovery, Inc.- Press Release
Jun 04, 2012: Xcovery Presents Phase I Clinical Results Of X-82 At ASCO 2012 Annual Meeting
May 18, 2012: Xcovery To Present Clinical Data Of X-82 AT American Society of Clinical Oncology
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Xcovery, Inc., Key Information
Xcovery, Inc., Key Facts
Xcovery, Inc. – Pipeline by Indication, 2012
Xcovery, Inc. – Pipeline by Stage of Development, 2012
Xcovery, Inc. – Monotherapy Products in Pipeline, 2012
Xcovery, Inc. – Phase I, 2012
Xcovery, Inc. – Pre-Clinical, 2012
Xcovery, Inc. – Pipeline By Therapeutic Class, 2012
Xcovery, Inc. - Pipeline By Target, 2012
Xcovery, Inc. – Pipeline By Route of Administration, 2012
Xcovery, Inc. – Pipeline Products By Mechanism of Action, 2012
Xcovery, Inc. – Recent Pipeline Updates, 2012
Xcovery, Inc. - Dormant Developmental Projects,2012

List of Figures
Xcovery, Inc. – Pipeline by Indication, 2012
Xcovery, Inc. – Pipeline by Stage of Development, 2012
Xcovery, Inc. – Monotherapy Products in Pipeline, 2012
Xcovery, Inc. – Pipeline By Therapeutic Class, 2012
Xcovery, Inc. - Pipeline By Target, 2012
Xcovery, Inc. - Pipeline Products By Mechanism of Action, 2012

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• eBay - Strong Execution
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• SunGard - Profile - US
• Ixia - Company Analysis
• Insight into Samsung Electronics' Notebook PC Business Model
• United Parcel Service - IT Sales Opportunities - 2009